CD160 and Alzheimer disease: Among identified NK cell subsets (i.e., NK0, NK1, NK2, and NK3), a unique NK1 subset is expanded in AD and characterized by expression of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2.